Consumer Defensive Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/13/2026 | CALL | $18.00 | 10,818 | +2,710 | +33.42% |
| 02/20/2026 | PUT | $14.00 | 17,608 | +2,520 | +16.70% |
| 04/17/2026 | CALL | $18.00 | 2,000 | +2,000 | |
| 04/17/2026 | PUT | $18.00 | 2,000 | +2,000 | |
| 02/13/2026 | CALL | $17.00 | 2,900 | +1,979 | +214.88% |
| 08/21/2026 | PUT | $14.00 | 1,872 | +1,723 | +1,156.38% |
| 02/20/2026 | PUT | $32.00 | 2,096 | -2,649 | -55.83% |
| 02/20/2026 | PUT | $30.00 | 2,539 | -3,057 | -54.63% |
| 06/18/2026 | CALL | $100.00 | 2,000 | -3,980 | -66.56% |
| 06/18/2026 | PUT | $40.00 | 2,000 | -3,980 | -66.56% |
| 01/15/2027 | CALL | $100.00 | 2,000 | -3,980 | -66.56% |
| 01/15/2027 | PUT | $40.00 | 2,000 | -3,980 | -66.56% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.78% | 3.57M | 30.96M |
| Vanguard Small-Cap Index Fund | 1.54% | 3.08M | 26.72M |
| iShares Russell 2000 ETF | 1.33% | 2.66M | 23.08M |
| Vanguard Small-Cap Growth Index Fund | 0.89% | 1.78M | 15.39M |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 0.84% | 1.68M | 14.61M |
| Vanguard Extended Market Index Fund | 0.79% | 1.59M | 13.76M |
| Fidelity Small Cap Index Fund | 0.50% | 997.91k | 8.65M |
| iShares Russell 2000 Growth ETF | 0.39% | 790.2k | 6.85M |
| TIAA-CREF Funds-Quant Small Cap Equity Fund | 0.36% | 717.3k | 6.22M |
| Fidelity Extended Market Index Fund | 0.31% | 621.62k | 5.39M |
Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market
02/12 02:02 pm
Benzinga
Read moreStock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
02/09 07:34 pm
The Motley Fool
Read moreHims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
02/09 05:07 pm
The Motley Fool
Read moreNovo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
02/09 03:30 pm
The Motley Fool
Read moreHims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
02/09 02:03 pm
Benzinga
Read moreNovo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
02/09 10:46 am
Benzinga
Read moreWhat's Going On With Novo Nordisk Stock On Friday?
02/06 02:51 pm
Benzinga
Read moreHims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
02/05 09:51 pm
GlobeNewswire Inc.
Read moreAmazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
02/05 09:15 pm
The Motley Fool
Read morePharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
02/05 08:53 pm
GlobeNewswire Inc.
Read moreHims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
02/05 01:51 pm
Benzinga
Read moreHUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
02/04 12:25 pm
The Motley Fool
Read moreThese 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More
02/02 03:08 pm
Benzinga
Read moreKelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch
01/26 02:00 pm
GlobeNewswire Inc.
Read more2 Top Stocks to Double Up On Right Now
01/20 08:05 pm
The Motley Fool
Read moreLooking For A Short Squeeze? 10 Stocks Ready To Rocket
01/16 11:41 am
Benzinga
Read moreStocks to Love in 2026
01/12 12:04 am
The Motley Fool
Read moreTop 10 Most Shorted Stocks: Lucid, MARA, Hims and More
12/29 11:30 am
Benzinga
Read moreHigh Short-Interest Stocks to Buy Before Q1 2026
12/10 11:12 am
Investing.com
Read moreWhy Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?
11/26 06:15 am
The Motley Fool
Read moreNovo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?
11/23 05:30 am
The Motley Fool
Read moreLooking For A Squeeze? Here Are The Top 10 Most Shorted Stocks
11/13 04:05 pm
Benzinga
Read more2 Strong Healthcare Stock Picks for Growth Investors
11/13 09:15 am
The Motley Fool
Read moreHims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?
11/09 05:35 am
The Motley Fool
Read moreStock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)
11/03 09:22 am
Benzinga
Read moreShould Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?
10/14 07:28 am
The Motley Fool
Read moreWhy Hims & Hers Stock Slipped Today
10/03 06:27 pm
The Motley Fool
Read moreThe Secret to Finding the Next Amazon Is Hiding in Plain Sight
10/01 03:15 am
The Motley Fool
Read more3 Healthcare Stocks Using AI to Drive Growth
09/30 05:04 pm
Investing.com
Read moreHims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
09/23 10:36 am
Investing.com
Read moreWhy Novo Nordisk Stock Popped Today
09/17 11:02 am
The Motley Fool
Read moreHims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
09/16 01:26 pm
Benzinga
Read moreHuge News for Hims & Hers Stock
09/16 11:28 am
The Motley Fool
Read moreHims & Hers Bets On Hormonal Health To Revive Investor Confidence
09/10 11:13 am
Benzinga
Read more4 Top Stocks to Buy in September
09/04 06:24 am
The Motley Fool
Read moreINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
08/25 10:57 am
GlobeNewswire Inc.
Read moreHims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman
08/24 10:26 am
GlobeNewswire Inc.
Read moreHIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS
08/24 09:46 am
GlobeNewswire Inc.
Read moreINVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS
08/23 09:45 am
GlobeNewswire Inc.
Read moreDEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
08/22 12:00 pm
GlobeNewswire Inc.
Read moreHIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS
08/21 10:22 pm
GlobeNewswire Inc.
Read moreHealthcare ETF Discount Highlights Value Ahead of Ozempic Growth Cycle
08/21 03:46 pm
Investing.com
Read moreHIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
08/20 04:00 pm
GlobeNewswire Inc.
Read moreINVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS
08/20 11:40 am
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing
08/20 10:00 am
GlobeNewswire Inc.
Read moreHims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.
08/19 04:54 pm
GlobeNewswire Inc.
Read moreHIMS Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Filing Deadline in Class Action Lawsuit
08/19 02:16 pm
GlobeNewswire Inc.
Read moreDeadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
08/19 12:00 pm
GlobeNewswire Inc.
Read more